Holocene Advisors, LP Dyne Therapeutics, Inc. Transaction History
Holocene Advisors, LP
- $29.2 Billion
- Q4 2024
A detailed history of Holocene Advisors, LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 2,348,161 shares of DYN stock, worth $17.5 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,348,161
Previous 1,982,640
18.44%
Holding current value
$17.5 Million
Previous $71.2 Million
22.32%
% of portfolio
0.19%
Previous 0.31%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
211Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$59.9 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$55.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$55.1 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$50.1 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$47.7 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $387M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...